Evidence map›Paper›PMID 35890252›Full record

ArticlePharmaceutics2022

Common Structural Pattern for Flecainide Binding in Atrial-Selective K

Yuliet Mazola, José C E Márquez Montesinos, David Ramírez, Leandro Zúñiga, Niels Decher, Ursula Ravens, Vladimir Yarov-Yarovoy, Wendy González

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Inhibitory Effects of Nobiletin on Voltage-Gated NaInternational journal of molecular sciences · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Yuliet MazolaCenter for Bioinformatics, Simulation and Modeling (CBSM), Universidad de Talca, Talca 3460000, Chile.
José C E Márquez MontesinosCenter for Bioinformatics, Simulation and Modeling (CBSM), Universidad de Talca, Talca 3460000, Chile.ORCID 0000-0002-4682-1969
David RamírezDepartamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción 4030000, Chile.ORCID 0000-0003-0002-1189
Leandro ZúñigaEscuela de Medicina, Centro de Investigaciones Médicas, Universidad de Talca, Talca 3460000, Chile.
Niels DecherInstitute for Physiology and Pathophysiology, Vegetative Physiology, Philipps-University of Marburg, 35043 Marburg, Germany.ORCID 0000-0002-9433-687X
Ursula RavensInstitut für Experimentelle Kardiovaskuläre Medizin, Universitäts-Herzzentrum Freiburg Bad Krotzingen, 79110 Freiburg im Breisgau, Germany.ORCID 0000-0003-3813-3127
Vladimir Yarov-YarovoyDepartment of Physiology and Membrane Biology, University of California, Davis, CA 95616, USA.
Wendy GonzálezCenter for Bioinformatics, Simulation and Modeling (CBSM), Universidad de Talca, Talca 3460000, Chile.ORCID 0000-0002-7535-6883
University of Talca · CLPhilipps University of Marburg · DEUniversitäts-Herzzentrum Freiburg-Bad Krozingen · DEUniversity of California, Davis · USUniversity of Concepción · CL

Funding

Agencia Nacional de Investigación y Desarrollo Becas Doctorales Y.M. y E.M.Agencia Nacional de Investigación y Desarrollo Fondecyt 1191133
6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Its treatment includes antiarrhythmic drugs (AADs) to modulate the function of cardiac ion channels. However, AADs have been limited by proarrhythmic effects, non-cardiovascular toxicities as well as often modest antiarrhythmic efficacy. Theoretical models showed that a combined blockade of Na

Indexed as

atrial fibrillationbinding site comparisondruggable binding sitedrug promiscuityflecainideKv1.5multi-targetNav1.5polypharmacology

Identifiers

PMID35890252
PMCPMC9318806
OpenAlexW4283652114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.